Articles
Why don't elephants get cancer?
US researchers may have solved an intriguing mystery — why do elephants rarely get cancer? [ + ]
Gene variant increases depression risk for abused children
Scientists have produced further evidence linking a particular variant of the brain's serotonin transporter (SERT) gene to an increased risk of severe depression in individuals who suffered abuse as children. [ + ]
Automated plate assessment system exceeds expectations
Shares in LBT Innovations rose almost 20% as the medical technology company received successful results from a clinical trial of its culture plate analysis technology. [ + ]
The risky business of cell culture
The process of cell culture is one which can be beneficial for modelling health and disease but is not without its risks — risks which many scientists are often willing to take.
[ + ]Paranta Biosciences commences cystic fibrosis trial
Paranta Biosciences has successfully closed a $7 million financing round, which it will use to fund the development of treatments for inflammatory and fibrotic lung diseases. [ + ]
The bubonic plague — 20 million years in the making?
Entomology researcher George Poinar, Jr has unearthed what he believes is a 20-million-year-old strain of the bubonic plague.
[ + ]Laboratory market transformation drives systems innovation
The fast-changing laboratory market is ripe for a new generation of information systems that meet the needs of a modern pathology environment.
[ + ]US$53.9m for Avita to support mass burn injuries
Avita Medical has been awarded a contract with BARDA, worth up to $53.9 million, which supports late-stage clinical development and procurement of Avita's ReCell autologous cell harvesting device under a mass casualty preparedness program. [ + ]
Trialled in the wild — the Tasmanian devil vaccine
Nineteen Tasmanian devils, who were recently immunised against the deadly devil facial tumour disease (DFTD), have been released into Narawntapu National Park as part of a program to test the vaccine in the wild for the very first time. [ + ]
The Daraprim price hike and the TPP
After a tumultuous week for Turing Pharmaceuticals — which saw the company raise the price of an essential medicine by over 4000%, only to lower it again in the face of universal criticism — an Australian intellectual property expert warns that similar incidents could occur as a result of the Trans-Pacific Partnership (TPP).
[ + ]No snow-white apple fairytale for Australia
A Canadian company has begun marketing two non-browning apple varieties that employ CSIRO's patented gene-silencing technology. But in GM-averse Australia, there are no takers — why? [ + ]
Diamond defects produce bright fluorescence
Japanese researchers have discovered that germanium defects in a diamond crystal lattice act as a reliable source for single photons, providing a promising new route to building components for quantum cryptography and biomarkers. [ + ]
Australia's 3D-printed ribs
Australia has contributed to an international collaboration that has led to a world-first in surgery — the implantation of a 3D-printed titanium sternum and rib cage into a Spanish cancer patient. [ + ]
Why does cancer cause weight loss?
An international research team has uncovered the cause of the muscle-wasting disease cachexia in cancer patients. Their study brings hope to the large number of people who suffer from this wasting condition. [ + ]
There's an app for that
Context and location aware mobile apps, integrated with allied technologies, are transforming business processes for biotech companies as they offer the promise of greater accuracy of reporting and improved safety and compliance.
[ + ]
